[NBIX] QoQ Quarter Result on 30-Sep-2022 [#Q3]

Stock
[NBIX] Neurocrine Biosciences, Inc.
Announcement Date
01-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- 505.33%
YoY- 204.44%
Quarter Report
NBIX's Result
NBIX's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 452,700 420,400 412,000 387,900 378,200 310,600 312,000 28.25%
PBT 121,600 -103,300 117,900 97,900 -23,300 21,400 -13,800 -
Tax 26,100 -26,700 28,900 29,400 -6,400 7,500 -6,500 -
NP 95,500 -76,600 89,000 68,500 -16,900 13,900 -7,300 -
Tax Rate -21.46% - -24.51% -30.03% - -35.05% - -
Total Cost 357,200 497,000 323,000 319,400 395,100 296,700 319,300 7.78%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin 21.10 -18.22 21.60 17.66 -4.47 4.48 -2.34 -
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS 0.98 -0.79 0.92 0.72 -0.18 0.15 -0.08 -
EPS Diluted 0.95 -0.79 0.88 0.69 -0.18 0.14 -0.08 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.